HCV & Substance Misuse

Post-HCV Treatment Follow-up and Reinfection

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • Other: 0.75
    • CPHCE: 1.00
  • Cost: Free
  • Release: Sep 6, 2019
  • Expires: Sep 5, 2022
  • Estimated Time to Complete:
    45 Minutes
  • Average User Rating:
    (3 Ratings)

Faculty

Takako S.  Schaninger Takako S. Schaninger, MD
Associate Professor, Medicine
University of Kentucky College of Medicine
Hospital Epidemiologist
VAMC
Lexington, Kentucky

Needs Statement

Virologic cure of hepatitis C does not mean a cure of advanced liver disease. Ongoing evaluation and management of liver disease is indicated for cirrhotic patients after achieving SVR. Non-hepatologist HCV care providers are not familiar with management of cirrhosis.

This module will increase knowledge of appropriate screening to prevent liver complications post SVR.

This activity has been approved by the KBML as meeting the statutory requirements of HB1

Target Audience

Health care providers making clinical decisions regarding screening methods.

Objectives

Upon completion of this education activity, participants will be able to:

  • Describe the benefits of SVR
  • Describe the screening strategies for HCC and esophageal varices
  • Evaluate patients at high risk for HCV reinfection

Accreditation

CME
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC). The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0418-H3.5-UK19a

ACGME Competencies

  • Patient care
  • Medical knowledge

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

CPHCE
University of Kentucky College of Public Health certifies that this educational activity was designated for 1.00 hour of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health. ()

Faculty Disclosure

No speaker or planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, the presentation might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

This activity is jointly provided by the University of Kentucky and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC).

In collaboration with Kentucky Aids Education Training Center (KY AETC).